Dexlansoprazole
- Product NDC
- 50090-5956
- 11-digit product format
- 500905956
- Labeler code
- 50090
- Product ID
- 50090-5956_dc2581d1-3173-4915-b53c-e89dd6e1c1a1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dexlansoprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA022287
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2022-01-01
- Marketing end
- 0000-00-00
- Substance
- DEXLANSOPRAZOLE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5956-0 | 50090595600 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (50090-5956-0) | 2022-04-06 | 0000-00-00 | No | No | Current |